Shopping Cart

Your shopping cart is currently empty

Trimetazidine

Name: Trimetazidine
Brand: TargetMol
SKU: T22444
Price: 30 USD
Availability: InStock
Rating: 5 (10 reviews)

😃Good

Catalog No. T22444Cas No. 5011-34-7

Trimetazidine is a non-haemodynamic antianginal agent that selectively inhibits the mitochondrial enzyme 3-ketoacyl coenzyme A thiolase (LC 3-KAT), thereby preventing β-oxidation of free fatty acids, with an IC50 value of 75 nM. Trimetazidine prevents ischaemia-reperfusion injury by altering cardiac metabolism, exhibiting antioxidant and anti-ischaemic effects.

Trimetazidine

😃Good

Purity: 99.9%

Catalog No. T22444Cas No. 5011-34-7

Pack Size	Price	USA Warehouse	Global Warehouse
5 mg	$32	In Stock	In Stock
10 mg	$44	In Stock	In Stock
25 mg	$57	In Stock	In Stock
50 mg	$70	In Stock	In Stock
1 mL x 10 mM (in DMSO)	$30	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.

Questions

Batch Information

Select Batch

Purity:99.9%

Appearance:Viscous

Color:White

Resource Download

COA LCMS HNMR

Product Introduction

Bioactivity

Description	Trimetazidine is a non-haemodynamic antianginal agent that selectively inhibits the mitochondrial enzyme 3-ketoacyl coenzyme A thiolase (LC 3-KAT), thereby preventing β-oxidation of free fatty acids, with an IC50 value of 75 nM. Trimetazidine prevents ischaemia-reperfusion injury by altering cardiac metabolism, exhibiting antioxidant and anti-ischaemic effects.
Targets&IC50	Long chain 3-ketoyl coenzyme A thiolase:75 nM
In vitro	Methods: Mouse C2C12 myoblasts were treated with Trimetazidine (50–200 μM, 6 hours), and cell viability was measured using CCK-8 reagent. Result: Trimetazidine at concentrations of 150 μM and 200 μM significantly reversed dexamethasone-induced cell death.[1]
In vivo	Methods: Trimetazidine (5 mg/kg, administered intraperitoneally for 12 consecutive days) was injected into C26 colon carcinoma mice to study the "exercise-mimicking" effects of trimetazidine in a cancer cachexia mouse model. Results: Trimetazidine enhanced metabolic adaptive mechanisms in cancer cachexia mice by mimicking the effects of exercise, including increased grip strength, elevated proportion of slow muscle fibers, upregulated PGC1α expression, and enhanced mitochondrial biogenesis and oxidative metabolism. [2]

Chemical Properties

Molecular Weight	266.34
Formula	C₁₄H₂₂N₂O₃
Cas No.	5011-34-7
Smiles	COc1ccc(CN2CCNCC2)c(OC)c1OC
Relative Density.	1.092 g/cm3

Storage & Solubility Information

Storage

keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 85 mg/mL (319.14 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (12.39 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.7546 mL	18.7730 mL	37.5460 mL	187.7300 mL
5 mM	0.7509 mL	3.7546 mL	7.5092 mL	37.5460 mL
10 mM	0.3755 mL	1.8773 mL	3.7546 mL	18.7730 mL
20 mM	0.1877 mL	0.9386 mL	1.8773 mL	9.3865 mL
50 mM	0.0751 mL	0.3755 mL	0.7509 mL	3.7546 mL
100 mM	0.0375 mL	0.1877 mL	0.3755 mL	1.8773 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc